Nightmares in Midlife May Point to Future Cognitive Decline, Dementia
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, July 12, 2024 -- Distressing dreams in middle-aged and older adults may indicate a higher risk for future cognitive decline and all-cause dementia, according to a study presented at EAN 2024, the 10th Congress of the European Academy of Neurology, held from June 29 to July 2 in Helsinki.
Abidemi Otaiku, M.D., from Imperial College London, and colleagues examined whether distressing dreams are associated with cognitive decline and dementia in people without Parkinson disease. The analysis included 605 middle-aged adults from the Midlife in the United States study who were followed for more than 13 years, as well as 2,600 older adults from the Osteoporotic Fractures in Men Study and the Study of Osteoporotic Fractures, followed for more than seven years.
The researchers found that compared with middle-aged adults who reported having no distressing dreams at baseline, those who reported having weekly distressing dreams had a fourfold higher risk for experiencing cognitive decline (adjusted odds ratio, 3.99). Dementia risk more than doubled in older adults (adjusted odds ratio, 2.21).
"Nightmares have a very strong link with many brain and other conditions, and I strongly believe that nightmares should be asked about more often by physicians," Otaiku said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-13 07:15
Read more
- Blood Test Might Spot Women in Labor at Risk for Preeclampsia
- Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
- Having a Preemie Baby Can Harm Job Prospects, Income
- Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
- Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions